INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

作者署名政策规定,不得将ChatGPT等AI聊天机器人列为作者。 模型中文摘要

Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

期刊鼓励作者在符合伦理和法律要求的前提下,将研究数据存入公共数据仓库、提供数据可用性声明并在论文中引用数据;无法共享数据时应在声明中说明原因。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免审批,并提供委员会全称、所属机构及批准编号;若无需伦理批准,须明确说明。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该刊为开放获取期刊,文章一经接受即免费在线发布,采用知识共享许可;同行评审通过后须支付3200美元的文章处理费,投稿本身不收费。 模型中文摘要

The International Journal of Biological Markers is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of p…

该刊采用单盲同行评审,审稿人姓名对作者保密;稿件先经初步评估,不符合要求可能被退回修改或直接拒稿,通过后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage严肃对待版权侵犯、抄袭及其他违反出版最佳实践的行为,作者应阅读Sage完整的抄袭政策。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

期刊接受已在预印本服务器发布的稿件,投稿时须填写预印本DOI并告知编辑部,且同行评审期间不得在预印本服务器更新稿件。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

临床试验须在首个受试者入组前或当时注册于WHO认可的公共试验注册库;迟注册的试验如有合理理由也可考虑,且注册库名称、URL和注册号须列于摘要末尾。 模型中文摘要

The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …